2013
London, UK, 26 November 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena™ (polidocanol injectable...
London, UK, 18 November 2013 18 November 2013: BTG plc (LSE: BTG), the specialist healthcare company today announces that Louise Makin, CEO will be presenting an overview of the company at the...
London, UK, 12 November 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim results for the six months ended 30 September 2013. Click here to down load the PDF
London, UK, 25 October 2013 BTG plc (LSE: BTG), the specialist healthcare company, will be announcing its interim results for the six months ended 30 September 2013 on Tuesday 12 November 2013. An...
London, UK, 03 October 2013 BTG plc (LSE: BTG), the specialist healthcare company, provides the following update for the six months ended 30 September 2013 ahead of the publication of its Interim...
London, UK, 18 September 2013 BTG plc (LSE: BTG), the specialist healthcare company, notes yesterday’s announcement by Sanofi and its subsidiary Genzyme, relating to the European Commission...
London, UK, 17 September 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces the sale of its brachytherapy business to Eckert & Ziegler Group, based in Berlin, Germany....
London, UK, 30 July 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces that the National Institute for Health and Care Excellence (NICE) has issued guidance recommending...
London, UK, 25 July 2013 Full data show a clinically meaningful reduction in symptom burden in patients with varicose veins caused by saphenofemoral junction incompetence BTG, the specialist...
London, UK, 16 July 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim management statement for the period from 1 April 2013 to 15 July 2013. During the...
London, UK, 15 July 2013 15 July 2013 BTG PLC COMPLETION OF ACQUISITION OF THERASPHERE® On 23 May 2013, BTG plc (BTG), the specialist healthcare company, announced that it had entered into an...
London, UK, 23 May 2013 THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA,...
London, UK, 20 May 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2013. Click here to download the PDF
London, UK, 03 May 2013 BTG, the specialist healthcare company is delighted to announce the start of the BTG Cycle Challenge which takes place over this weekend. 13 riders from each of our three...
London, UK, 12 April 2013 BTG plc (LSE: BTG), the specialist healthcare company, announces that the New Drug Application (NDA) seeking approval of Varisolve® (polidocanol endovenous microfoam...
London, UK, 04 April 2013 BTG plc (LSE: BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2013 ahead of the publication of its Final Results on 20...
London, UK, 21 February 2013 BTG plc (LSE: BTG), the specialist healthcare company today announces that Rolf Soderstrom, BTG’s Chief Financial Officer, will be presenting an overview of the...
London, UK, 04 February 2013 BTG plc (LSE: BTG), the specialist healthcare company, today announces that a New Drug Application (NDA) seeking approval of Varisolve® (polidocanol endovenous...
London, UK, 31 January 2013 BTG plc (LSE: BTG), the specialist healthcare company, provides the following update for the period from 1 October 2012 to 31 January 2013. The Group’s trading during...
London, UK, 07 January 2013 BTG plc (LSE: BTG), the specialist healthcare company today announces that Louise Makin, CEO will be presenting an overview of the company at the 31st Annual J.P....